FindTrial
Sign In

Evaluation and early diagnosis of abnormal uterine bleeding in pre and perimenopausal women using Ultrasound

Evaluation of Abnormal Uterine Bleeding using International Endometrial Tumor Analysis Model

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/070299
Enrollment
90
Registered
2024-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: nil: nil Control Intervention1: NIL: NIL

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: premenopausal women presenting with abnormal uterine bleeding Postmenopausal bleeding women consenting to be a part of this study

Exclusion criteria

Exclusion criteria: 1.) women under 30 years and above 75 years of age 2.) women presenting with features of leiomyoma 3.) women not consenting to be a part of the study

Design outcomes

Primary

MeasureTime frame
to look at efficacy of using Ultrasound features of International Endometrial Tumour Analysis Guidelines in diagnosing abnormal endometrial pathologies (benign or malignant) in women with abnormal uterine bleedingTimepoint: 6-8 weeks, 2 months—

Secondary

MeasureTime frame
to reduce time taken for diagnosis for any endometrial pathology using USG featuresTimepoint: 6-8 weeks, 2 months—

Countries

India

Contacts

Public ContactDr Diya Ghoshal

Department of Obsteterics and gynaecology, Kasturba Medical College, MAHE

jyothi.shetty@manipal.edu9845973697

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026